# Antimicrobial / Antifungal Activity ### Polydatin, Resveratrol, and Antimicrobial / Antifungal Activity ### Overview Polydatin and resveratrol are both classified as phytoalexins — compounds plants synthesise specifically as a defence response against microbial pathogens, including fungi, bacteria, and viruses. This is the original biological purpose of these molecules in the plant kingdom, and it appears that some of those antimicrobial properties translate meaningfully into human biology. In the context of cancer, this is particularly relevant given the rapidly expanding evidence that the tumour mycobiome — the community of fungi found within and around tumour tissue — plays a role in cancer initiation, progression, immune evasion, and treatment resistance. *** ### Direct antifungal activity Resveratrol has demonstrated direct antifungal activity against clinically relevant pathogenic fungi in laboratory studies: * Against Candida albicans, resveratrol acts as a fungal apoptosis inducer, triggering ROS accumulation inside fungal cells, causing loss of mitochondrial membrane potential, and activating caspase-dependent cell death pathways — the same general mechanism by which it induces apoptosis in cancer cells * Resveratrol shows synergistic antifungal effects when combined with standard antifungal drugs, including fluconazole, ketoconazole, and itraconazole, against clinical Candida isolates — importantly, including fluconazole-resistant strains — reducing minimum inhibitory concentrations to as little as one-sixty-fourth of the standard dose when combined with resveratrol * Against Aspergillus fumigatus, resveratrol affects membrane integrity, disrupts hyphal morphology, and suppresses inflammatory signalling through the Dectin-1/p38 MAPK pathway, reducing fungal load in animal models Polydatin itself also carries direct antimicrobial properties as a phytoalexin, confirmed in multiple pharmacology reviews, though the antifungal mechanism is less extensively mapped for polydatin in its intact glucoside form than for resveratrol. *** ### The tumour mycobiome: what the emerging evidence shows The presence of fungi in human tumours is no longer a fringe observation. Large-scale genomic and tissue analyses published from 2022 onwards have identified cancer type-specific fungal signatures across multiple tumour types: * Candida species are significantly enriched in colorectal cancer, where their presence correlates with decreased patient survival; Candida DNA detection in GI tumours is predictive of worse outcomes * Malassezia species are enriched in pancreatic cancer, where they appear to promote oncogenesis by activating the complement cascade * Blastomyces species have been identified in lung and breast cancer tissues * Aspergillus-Candida mycotypes define one of three distinct intratumoral fungal clusters, each associated with different immune response patterns in the tumour microenvironment * Three distinct mycotypes have been characterised — F1 (Malassezia-dominated), F2 (Aspergillus-Candida), and F3 (multi-genera including Yarrowia) — each associated with different immune profiles and potentially different prognosis Importantly, the presence of intratumoural fungi may not be coincidental contamination. Evidence suggests some fungi actively contribute to tumourigenesis by inducing genomic instability, accumulating myeloid-derived suppressor cells (MDSCs), which suppress anti-tumour immunity, stimulating pro-inflammatory and pro-tumour cytokines, and potentially driving some of the hallmarks of cancer progression, including invasion and immune evasion. *** ### Why does this connect back to polydatin and resveratrol? A plant compound that is itself a phytoalexin — synthesised by plants to kill invading fungi — and that also activates a tumour-specific enzyme (CYP1B1) to produce a potent anticancer metabolite (piceatannol) inside cancer cells may be working through multiple converging layers simultaneously: * Direct antifungal activity against intratumoral pathogens such as Candida and Aspergillus * CYP1B1-mediated conversion to piceatannol, which eliminates cancer cells and may also represent an evolved response to intracellular fungal presence * Gut microbiome modulation — polydatin has been shown in animal models to have a more significant regulatory effect on the gut microbiome community structure than resveratrol alone, potentially supporting a healthier balance between commensal bacteria and fungal overgrowth at the gut level * Immune support — reducing the fungal burden in the tumour microenvironment may help restore effective macrophage-mediated clearance and relieve immunosuppression **Did you read the Polydatin anti-cancer mechanisms page dedicated to CYP1B1?** The direct link is [CYP1B1 Rescue Mechanism](/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms/cyp1b1-rescue-mechanism.md). *** ### Mark Lintern and the Cell Suppression Theory Mark Lintern is a UK-based researcher who spent eight years developing what he calls the Cell Suppression Theory of Cancer. His work challenges the conventional DNA mutation theory of cancer and proposes that intracellular pathogens — including fungi — suppress normal cell function and drive the hallmarks of cancer through a mechanism of suppression rather than direct genetic mutation alone. Lintern argues that CYP1B1 overexpression in cancer cells may represent the body's own attempted antifungal and cellular rescue response, and that restoring this response through targeted phytonutrients such as resveratrol and salvestrols, combined with antifungal support and metabolic restoration, may allow cells to recover normal function.

Learn more about Mark Lintern and his work:

Lintern presented the Cell Suppression Theory in February 2023 to a panel of ten experts with over 200 medical professionals present. The expert panel validated his theory with an average score of 7 out of 10, and the audience score was slightly higher at 7.7. He is collaborating with the cancer care charity Yes to Life and with research groups exploring clinical and laboratory-based investigation of Cell Suppression Theory-aligned treatment approaches. The Cell Suppression Theory remains a hypothesis under active development — it is not yet a peer-reviewed mainstream consensus. It is included here because it provides a coherent theoretical framework that integrates several strands of evidence discussed in this workbook, including CYP1B1 biology, the tumour mycobiome, and the role of phytoalexins such as polydatin and resveratrol. Group members are encouraged to engage with Lintern's work directly and form their own views. Ways to explore Mark Lintern's work further: * Six-part interview series with Robin Daly of Yes to Life, available on demand and on YouTube: [www.cellsuppression.com/in-conversation-with-robin-daly](http://www.cellsuppression.com/in-conversation-with-robin-daly) * The book — The Cancer Resolution, written for cancer patients and including alternative treatment approaches: [www.cellsuppression.com/the-book](http://www.cellsuppression.com/the-book) * 2023 Live Expert Panel Presentations, recordings available for purchase: [www.cellsuppression.com/event-presentations](http://www.cellsuppression.com/event-presentations) * Mark Lintern's website, including the lightbulb moment that inspired his research: [www.cellsuppression.com](http://www.cellsuppression.com/)

*** ### Complementary antifungal support: Bacillus subtilis For group members exploring an antifungal approach alongside polydatin and resveratrol, Bacillus subtilis — the bacterium used to produce natto and from which [nattokinase](https://www.mcsformulas.com/vitamins-supplements/nattokinase/ref/14) is derived — has demonstrated direct antifungal properties in preclinical research: * Bacillus subtilis natto can deconstruct fungal cell walls and use complex fungal material as a carbon source, indicating an enzymatic capacity to break down fungal structures * It secretes proteases that degrade fungal cell wall proteins, and induces chitinase production in the presence of complex fungal material — chitinases being enzymes that break down chitin, the structural polymer of most fungal cell walls * This makes Bacillus subtilis a mechanistically logical complementary support alongside resveratrol/polydatin in an antifungal-oriented protocol, operating at a different level — the extracellular degradation of fungal structures, particularly in the gut This is preclinical data, not clinical trial evidence. Its use in the context of cancer and mycobiome support remains investigational and should be discussed with a clinician. ### **References for Antifungal Activity and Tumour Mycobiome** Recent Progress in Research on Mitochondrion-Targeted Antifungal Mechanisms of Resveratrol\ Antifungal activity of resveratrol derivatives against Candida species including fluconazole-resistant strains\ Resveratrol antifungal activity against Aspergillus fumigatus\ Fungi and tumours: The role of fungi in tumorigenesis\ The mycobiome in human cancer — analytical challenges, molecular mechanisms, and clinical implications\ Fungi and cancer: unveiling the complex role of fungal infections in tumour biology\ Antifungal properties of plant compounds in cancer-relevant fungi including Candida and Aspergillus\ Bacillus subtilis natto antifungal activity — cell wall deconstruction and chitinase induction\ Resveratrol crosses the blood-brain barrier — measurable in cerebrospinal fluid of Alzheimer's patients\ Resveratrol restores blood-brain barrier integrity in Alzheimer's disease\ Polydatin has greater regulatory effect on gut microbiome community structure than resveratrol\ *** {% hint style="warning" %} This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use. {% endhint %} {% hint style="info" %} © 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text. {% endhint %} --- # Agent Instructions: Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter: ``` GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/antimicrobial-antifungal-activity.md?ask= ``` The question should be specific, self-contained, and written in natural language. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.